Novel demonstration of conformationally modified tau in sporadic inclusion-body myositis muscle fibers

Neuroscience Letters

Volumn 503, Issue 3, 2011, Pages 229-233

  Nogalska, Anna ^a   D'Agostino, Carla ^a   Engel, W King ^a   Askanas, Valerie ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alz50; Alzheimer disease; Conformationally modified tau; MC1; Paired helical filaments; Sporadic inclusion body myositis; TG3

Indexed keywords

PROTEIN P62; PYRIDOXAL 5 PHOSPHATE; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ANTIBODY LABELING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INCLUSION BODY MYOSITIS; MUSCLE BIOPSY; MUSCLE CELL; NEUROFIBRILLARY TANGLE; OUTCOME ASSESSMENT; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION;

AGED; ALZHEIMER DISEASE; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BIOPSY; BLOTTING, WESTERN; ENDOPLASMIC RETICULUM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; MYOSITIS, INCLUSION BODY; PHOSPHORYLATION; PROTEIN CONFORMATION; TAU PROTEINS;

EID: 80053247082     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.08.042     Document Type: Article

References (37)

1. Askanas V., Engel W.K. Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains. Acta Neuropathol. 2008, 116:583-595.
2. Askanas V., Engel W.K. Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-beta42 oligomers and phosphorylated tau. Presse Med. 2011, 40:e219-e235.
3. Askanas V., Engel W.K., Bilak M., Alvarez R.B., Selkoe D.J. Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am. J. Pathol. 1994, 144:177-187.
4. Askanas V., Engel W.K., Nogalska A. Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation. Brain Pathol. 2009, 19:493-506.
5. Barghorn S., Mandelkow E. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry 2002, 41:14885-14896.
6. Carmel G., Mager E.M., Binder L.I., Kuret J. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J. Biol. Chem. 1996, 271:32789-32795.
7. Dalakas M.C. Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Curr. Opin. Pharmacol. 2010, 10:346-352.
8. Davies P., Vincent I.J. On the role of tau phosphorylation in the formation of PHF. Neurobiol. Aging 1995, 16:420-422.
9. Fratta P., Engel W.K., McFerrin J., Davies K.J.A., Lin S.W., Askanas V. Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in AbPP-overexpressing cultured human muscle fibers. Am. J. Pathol. 2005, 167:517-526.
10. Gong C.X., Iqbal K. Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease. Curr. Med. Chem. 2008, 15:2321-2328.
11. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:4913-4917.
12. Honson N.S., Kuret J. Tau aggregation and toxicity in tauopathic neurodegenerative diseases. J. Alzheimers Dis. 2008, 14:417-422.
13. Iqbal K., Grundke-Iqbal I. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. J. Cell. Mol. Med. 2008, 12:38-55.
14. Iqbal K., Wang X., Blanchard J., Liu F., Gong C.X., Grundke-Iqbal I. Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial. Biochem. Soc. Trans. 2010, 38:962-966.
15. Jicha G.A., Berenfeld B., Davies P. Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease. J. Neurosci. Res. 1999, 55:713-723.
16. Jicha G.A., Bowser R., Kazam I.G., Davies P., Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau J. Neurosci. Res. 1997, 48:128-132.
17. Jicha G.A., Lane E., Vincent I., Otvos L., Hoffmann R., Davies P. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. J. Neurochem. 1997, 69:2087-2095.
18. Jin M., Shepardson N., Yang T., Chen G., Walsh D., Selkoe D.J. Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5819-5824.
19. Kannanayakal T.J., Mendell J.R., Kuret J. Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis. Neurosci. Lett. 2008, 431:141-145.
20. Keller J.N., Hanni K.B., Markesbery W.R. Impaired proteasome function in Alzheimer's disease. J. Neurochem. 2000, 75:436-439.
21. Kitazawa M., Trinh D.N., LaFerla F.M. Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta. Ann. Neurol. 2008, 64:15-24.
22. Klein W.L., Stine W.B., Teplow D.B. Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol. Aging 2004, 25:569-580.
23. Ksiezak-Reding H., Dickson D.W., Davies P., Yen S.H. Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:3410-3414.
24. LaFerla F.M. Pathways linking Abeta and tau pathologies. Biochem. Soc. Trans. 2010, 38:993-995.
25. Lindholm D., Wootz H., Korhonen L. ER stress and neurodegenerative diseases. Cell Death Differ. 2006, 13:385-392.
26. Mirabella M., Alvarez R.B., Bilak M., Engel W.K., Askanas V. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies. J. Neuropathol. Exp. Neurol. 1996, 55:774-786.
27. Nixon R.A., Yang D.S. Autophagy failure in Alzheimer's disease-locating the primary defect. Neurobiol. Dis. 2011, 43:38-45.
28. Nogalska A., D'Agostino C., Engel W.K., Klein W.L., Askanas V. Novel demonstration of amyloid-beta oligomers in sporadic inclusion-body myositis muscle fibers. Acta Neuropathol 2010, 120:661-666.
29. Nogalska A., D'Agostino C., Terracciano C., Engel W.K., Askanas V. Impaired autophagy in sporadic inclusion-body myositis and in endoplasmic reticulum stress-provoked cultured human muscle fibers. Am. J. Pathol. 2010, 177:1377-1387.
30. Nogalska A., Terracciano C., D'Agostino C., King Engel W., Askanas V. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. Acta Neuropathol 2009, 118:407-413.
31. Spires-Jones T.L., Stoothoff W.H., de Calignon A., Jones P.B., Hyman B.T. Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci. 2009, 32:150-159.
32. Sy M., Kitazawa M., Medeiros R., Whitman L., Cheng D., Lane T.E., Laferla F.M. Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am. J. Pathol. 2011, 178:2811-2822.
33. Terracciano C., Nogalska A., Engel W.K., Askanas V. In AbetaPP-overexpressing cultured human muscle fibers proteasome inhibition enhances phosphorylation of AbetaPP751 and GSK3beta activation: effects mitigated by lithium and apparently relevant to sporadic inclusion-body myositis. J. Neurochem. 2010, 112:389-396.
34. Vattemi G., Nogalska A., King Engel W., D'Agostino C., Checler F., Askanas V. Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis. Acta Neuropathol 2009, 117:569-574.
35. Weaver C.L., Espinoza M., Kress Y., Davies P. Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol. Aging 2000, 21:719-727.
36. Wilczynski G.M., Engel W.K., Askanas V. Association of active extracellular signal-regulated protein kinase with paired helical filaments of inclusion-body myositis muscle suggests its role in inclusion-body myositis tau phosphorylation. Am. J. Pathol. 2000, 156:1835-1840.
37. Wilczynski G.M., Engel W.K., Askanas V. Cyclin-dependent kinase 5 colocalizes with phosphorylated tau in human inclusion-body myositis paired-helical filaments and may play a role in tau phosphorylation. Neurosci. Lett. 2000, 293:33-36.